TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Price to free cash flow ratio
Latest
-0.93
↑ 90% vs avg
Percentile
P83
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-9.61
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.93 | +68.7% |
| 2024 | -2.97 | +49.9% |
| 2023 | -5.93 | -1025.0% |
| 2022 | -0.53 | +71.3% |
| 2021 | -1.84 | +94.9% |
| 2020 | -36.06 | -89.6% |
| 2019 | -19.02 | - |